Nonprofit · EIN 13-6180380
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Tax-exempt · ALEXANDRIA, VA 22314
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $159,100,585 | $143,670,256 | $15,430,329 | $321,716,381 | $111,219,799 | $210,496,582 |
| December 31, 2023 | 990 | $174,337,293 | $155,488,043 | $18,849,250 | $296,538,439 | $112,691,951 | $183,846,488 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $7,681,674
- Program service revenue
- $137,635,933
- Investment income
- $9,082,224
- Royalties
- $1,882,508
- Net rental income
- $2,730,258
- Net gain from sales of assets
- $2,581,690
- Other revenue
- $4,700,754
Expenses
- Grants and similar amounts paid
- $5,363,509
- Compensation of officers, directors and key employees
- $5,964,017
- Other salaries and wages
- $40,929,791
- Salaries, compensation and benefits (total)
- $59,311,958
- Professional fundraising fees
- $0
- Legal fees
- $288,854
- Accounting fees
- $174,258
- Occupancy
- $3,410,473
- Travel
- $5,970,686
- Depreciation
- $5,065,126
- Program services (functional)
- $109,621,340
- Management and general (functional)
- $34,048,916
Balance sheet and other
- Total assets, start of year
- $296,538,439
- Total assets, end of year
- $321,716,381
- Total liabilities, end of year
- $111,219,799
- Net assets, end of year
- $210,496,582
- Land, buildings and equipment
- $64,850,297
- Publicly traded securities
- $210,045,111
- Net assets without donor restrictions
- $210,386,731
- Net assets with donor restrictions
- $109,851
- Gross unrelated business income
- $14,268,653
- Gross receipts
- $177,189,397
- Employees
- 488
- Volunteers
- 5,127
- Year formed
- 1965
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| CLIFFORD A HUDIS MD | CEO Officer | 30 | $1,114,041 | $25,875 |
| DINA MICHELS ESQ | SECRETARY, EVP & COO Officer | 37.5 | $710,762 | $47,358 |
| JULIE R GRALOW MD | EVP & CMO Key employee | 37.5 | $657,910 | $47,358 |
| NANCY DALY MS MPH | EVP & CONQUER CANCER CEO Key employee | 1 | $536,218 | $47,217 |
| CHRISTOPHER MERLAN | EVP & CHIEF DIGITAL OFFICER Key employee | 37.5 | $495,256 | $50,013 |
| CARMEN JACKSON | CLQ CEO Former | 0 | $511,604 | $0 |
| STEPHEN GRUBBS MD | VP, CARE DELIVERY Highest-paid employee | 37.5 | $459,466 | $46,603 |
| KRISTEN NEESE | CHIEF MARKETING & COMMUNICATIONS OFFICER Highest-paid employee | 37.5 | $387,841 | $50,013 |
| DEBORAH KAMIN PHD | VP, POLICY/ADVOCACY Highest-paid employee | 37.5 | $389,727 | $47,217 |
| PAULA KING | CHIEF HUMAN RESOURCES OFFICER Highest-paid employee | 37.5 | $379,435 | $50,013 |
| MELISSA TAI ESQ | VP, CEIL & GENERAL COUNSEL Highest-paid employee | 29.5 | $369,986 | $55,293 |
| ANGELA COCHRAN | VP, PUBLISHING Key employee | 37.5 | $351,613 | $44,703 |
| AMANDA DAVIS-AITKEN | VICE PRESIDENT, MEETING SERVICES Key employee | 37.5 | $351,635 | $36,612 |
| BARTON LAWYER | VICE PRESIDENT - IT Key employee | 37.5 | $316,766 | $53,205 |
| MELINDA O'LEARY | CFO (PARTIAL YEAR) Officer | 30 | $259,970 | $24,887 |
25 more people on this return
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JAMIE VON ROENN MD | VP, EDU. (PARTIAL YEAR) Key employee | 37.5 | $253,146 | $27,866 |
| JULIA CLOSE MD | EVP & CHIEF ED. OFFICER (PARTIAL YR) Key employee | 37.5 | $183,601 | $20,070 |
| EVERETT E VOKES MD | PAST PRESIDENT (PARTIAL YEAR) Trustee or director, Officer | 1 | $0 | $0 |
| ERIC P WINER MD | CHAIR/PAST PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| LYNN M SCHUCHTER MD | PRESIDENT/CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| ROBIN ZON MD | PRESIDENT-ELECT/PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| ERIC J SMALL MD | PRESIDENT-ELECT(PARTIAL YEAR) Trustee or director, Officer | 1 | $0 | $0 |
| ELIZABETH R PLIMACK MD MS | TREASURER (PARTIAL YEAR) Trustee or director, Officer | 1 | $0 | $0 |
| TAOFEEK K OWONIKOKO MD PHD | TREASURER-ELECT/TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| CAROLYN B HENDRICKS MD | TREASURER-ELECT (PARTIAL YEAR) Trustee or director, Officer | 1 | $0 | $0 |
| FREDRICK CHITE ASIRWA MD MBCHB | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| LISA A CAREY MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| MARIANA CHAVEZ MACGREGOR MD MSC | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| TONI K CHOUEIRI MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| JHANELLE E GRAY MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| TARA O HENDERSON MD MPH | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| CLARISSA MATHIAS MD PHD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| KATHLEEN N MOORE MD MS | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ANN H PARTRIDGE MD MPH | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| DEBRA A PATT MD PHD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| GLADYS I RODRIGUEZ MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ABBY R ROSENBERG MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| ENRIQUE SOTO PEREZ DE CELIS MD MSC | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| JENNIFER TEMEL MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| KAREN M WINKFIELD MD PHD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 39 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| CLIFFORD A HUDIS MD | CEO Officer | 30 | $1,060,801 | $24,750 |
| DINA MICHELS ESQ | SECRETARY, EVP & COO Officer | 37.5 | $685,749 | $42,792 |
| JULIE R GRALOW MD | EVP & CMO Key employee | 37.5 | $632,400 | $42,792 |
| CARMEN JACKSON | CEO - CLQ Key employee | 37.5 | $515,125 | $49,419 |
| NANCY DALY MS MPH | EVP & CONQUER CANCER CEO Key employee | 1 | $516,637 | $42,677 |
| CHRISTOPHER MERLAN | EVP & CHIEF DIGITAL OFFICE Key employee | 37.5 | $475,728 | $44,731 |
| LINDA JENSEN | EVP & CFO Officer | 30 | $477,532 | $42,792 |
| JAMIE VON ROENN MD MED | VP, EDU., SCIENCE & PROF. Key employee | 37.5 | $457,512 | $33,834 |
| STEPHEN GRUBBS MD | VP, CARE DELIVERY Highest-paid employee | 37.5 | $445,051 | $42,606 |
| KRISTEN NEESE | CHIEF MARKETING & COMMUNICATIONS OFFICER Highest-paid employee | 37.5 | $363,368 | $44,731 |
| PAULA KING | CHIEF HUMAN RESOURCES OFFICER Highest-paid employee | 37.5 | $362,762 | $44,731 |
| DEBORAH KAMIN PHD | VP, POLICY/ADVOCACY Highest-paid employee | 30 | $356,959 | $42,677 |
| MELISSA TAI | VP, CEIL & GENERAL COUNSEL Highest-paid employee | 29.5 | $350,115 | $49,281 |
| SEAN KHOZIN MD | FORMER CLQ CEO Former | 37.5 | $395,769 | $0 |
| ANGELA COCHRAN | VP, PUBLISHING Key employee | 37.5 | $336,979 | $40,401 |
| AMANDA DAVIS-AITKEN | VICE PRESIDENT, MEETING SV Key employee | 37.5 | $338,635 | $33,749 |
| BARTON LAWYER | VICE PRESIDENT - IT Key employee | 37.5 | $303,038 | $47,169 |
| EVERETT E VOKES MD | CHAIR/PAST PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| ERIC P WINER MD | PRESIDENT/CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| LYNN M SCHUCHTER MD | PRESIDENT-ELECT/PRESIDENT Trustee or director, Officer | 1 | $0 | $0 |
| ROBIN ZON MD | PRESIDENT-ELECT Trustee or director, Officer | 1 | $0 | $0 |
| LORI J PIERCE MD | PAST PRESIDENT (PARTIAL YEAR) Trustee or director, Officer | 1 | $0 | $0 |
| ELIZABETH A MITTENDORF MD PHD MHC | TREASURER (PARTIAL YEAR) Trustee or director, Officer | 1 | $0 | $0 |
| ELIZABETH R PLIMACK MD MS | TREASURER-ELECT/TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| TAOFEEK K OWONIKOKO MD PHD | TREASURER-ELECT Trustee or director, Officer | 1 | $0 | $0 |
| FREDRICK CHITE ASIRWA MD MBCHB | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ETHAN M BASCH MD MSC | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| LISA A CAREY MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| MARIANA CHAVEZ MACGREGOR MD MSC | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| TARA O HENDERSON MD MPH | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| CAROLYN B HENDRICKS MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| KATHLEEN N MOORE MD MS | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| ANN H PARTRIDGE MD MPH | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| DEBRA PATT MD PHD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| ENRIQUE SOTO PEREZ DE CELIS MD MSC | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| GLADYS I RODRIGUEZ MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| JENNIFER TEMEL MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| MICHAEL A THOMPSON MD PHD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 |
| KAREN M WINKFIELD MD PHD | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 2318 MILL RD STE 800, ALEXANDRIA, VA 22314-6834
- In care of
- % DINA L MICHELS
- Principal officer (990 for 2024)
- CLIFFORD HUDIS MD CEO, 2318 MILL ROAD 800, ALEXANDRIA, VA 22314
- Signed the 990
- MELINDA O'LEARY, CFO
- Phone
- (571) 483-1300
- Website
- WWW.ASCO.ORG
- Return prepared by
- COHNREZNICK ADVISORY LLC
Mission
SEE SCHEDULE O:
Program accomplishments
- SEE SCHEDULE O:SCIENTIFIC & MEDICAL EDUCATION:ASCO'S MEETING PORTFOLIO DELIVERS, TO ASCO'S CORE AUDIENCE OF HEALTH PROFESSIONALS, THE SCIENCE AND EDUCATION CRITICAL TO IMPROVING PATIENT CARE AND CLINICAL PRACTICE BY HOSTING CONFERENCES THAT BRING TOGETHER FACULTY AND PRACTITIONERS BOTH IN-PERSON AND ONLINE. IN 2024, ASCO'S PREMIER ANNUAL MEETING, THROUGH OVER 200 SESSIONS, REACHED AN AUDIENCE OF 36,400 PROFESSIONALS, INCLUDING OVER 14,400 PROFESSIONALS FROM 140 NON-US COUNTRIES, BOTH IN-PERSON AND ONLINE. THROUGH ASCO'S ADDITIONAL MEETINGS, THE ASCO GASTROINTESTINAL CANCERS SYMPOSIUM, THE ASCO GENITOURINARY CANCERS SYMPOSIUM, THE ASCO QUALITY CARE SYMPOSIUM, ASCO BREAKTHROUGH, AND THE BEST OF ASCO MEETING, A FURTHER 10,400 PROFESSIONALS, OVER 4,100 OF WHOM WERE OUTSIDE THE UNITED STATES, BENEFITED FROM THE EDUCATION, SCIENCE, AND NETWORKING THAT ASCO PROVIDED.Expenses $70,800,952 · grants $5,283,009 · revenue $109,069,704
- SEE SCHEDULE O:RESEARCH INITIATIVES - TAPUR/CENTRA:ASCO'S CENTER FOR RESEARCH AND ANALYTICS "(CENTRA)" LEADS ASCO'S EFFORTS IN RESEARCH AND RELATED TO CLINICAL CANCER RESEARCH. MAJOR PROGRAMS AND PROJECTS INCLUDE: (1) THE TARGETED AGENT AND PROFILING UTILIZATION REGISTRY (TAPUR) STUDY, WHICH IS A PRECISION MEDICINE BASKET TRIAL THAT INVESTIGATES THE EFFICACY OF MORE THAN 15 DIFFERENT ANTI-CANCER TARGETED AGENTS IN PATIENTS WITH ADVANCED CANCERS AND HAS ENROLLED NEARLY 3,000 PATIENTS SINCE IT OPENED IN 2016. TAPUR CONTINUES TO PUBLISH TRIAL RESULTS IN PEER-REVIEWED CLINICAL CANCER RESEARCH JOURNALS AND PRESENT RESULTS AT CLINICAL CANCER RESEARCH CONFERENCES; (2) ASCO'S MEMBER RESEARCH SURVEY POOL, WHICH FACILITATES RESEARCH OF CANCER CARE PROVIDERS BY DISSEMINATING SURVEYS FROM MERITORIOUS SURVEY RESEARCH PROJECTS TO ASCO MEMBERS WHO HAVE AGREED TO BE A PART OF THE SURVEY POOL; (3) THE STATE OF CANCER CARE IN AMERICA PROGRAM, WHICH ASSESSES AND REPORTS ON THE STATE OF AND CHANGES IN CANCER CARE IN THE US; (4) ASCO'S WORK IN IMPROVING ACCESS TO CLINICAL TRIALS THROUGH TRAINING FOR SITES; AND (5) A PATIENT-CENTERED CLINICAL TRIAL, THE CDK4/6 INHIBITOR DOSING STUDY, WHICH OPENED TO ENROLLMENT IN DECEMBER 2024 AND EVALUATES STANDARD VS. TITRATED DOSING APPROACHES FOR PATIENTS AGE 65 AND OLDER WITH HR+/HER2- METASTATIC BREAST CANCER. CENTRA ALSO SUPPORTS WORKSHOPS, MEETINGS, AND RESEARCH PROJECTS WITH OTHER STAKEHOLDERS IN CANCER RESEARCH, INCLUDING THE NCI, THE FDA'S ONCOLOGY CENTER FOR EXCELLENCE, AND OTHER NON-PROFIT GROUPS, SUCH AS THE FRIENDS OF CANCER RESEARCH.Expenses $9,374,885 · revenue $4,963,700
- SEE SCHEDULE O:QUALITY OF CARE INITIATIVES:QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) IS A QUALITY SELF-ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES. QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICES TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. PRACTICES PARTICIPATE ANNUALLY AND OVER 263 PRATICES PARTICAPTED IN 2024. QUALITY TRAINING PROGRAM. ASCO'S QUALITY TRAINING PROGRAM IS DESIGNED TO EDUCATE AND TRAIN HEMATOLGY-ONOCOLOGY PRACTICE TEAMS ON THE TECHNIQUES OF CLINICAL CARE AND OPERATIONAL PERFORMANCE QUALITY IMPROVEMENT. 290 ONCOLOGY PROFESSIONALS RECEIVED TRAINING IN 2024.GUIDELINES. ASCO'S GUIDELINES PROGRAM ENGAGES WITH MORE THAN 1,000 ASCO MEMBER VOLUNTEERS, ON A YEARLY BASIS, TO DEVELOP EXPERT RECOMMENDATIONS AND STANDARDS DESIGNED TO PROMOTE CONSISTENT, SAFE DELIVERY OF HIGH-QUALITY CANCER CARE WORLDWIDE. CLINICAL CONTENT IS DISSEMINATED USING PUBLISHED ARTICLES, RECOMMENDATION TABLES, ALGORITHMS, PODCASTS, VISUAL ABSTRACTS, AND OTHER RESOURCES ACCESSIBLE THROUGH ASCO JOURNALS, THE ASCO WEBSITE, AND THE ASCO GUIDELINES APP. GUIDELINES ARE AMONG THE MOST READ ARTICLES IN THE JOURNAL OF CLINICAL ONCOLOGY (JCO), WITH OVER 1.1 MILLION DOWNLOADS AND 503 CITATIONS IN 2024. ASCO PUBLISHES BETWEEN 25 AND 30 NEW OR UPDATED GUIDELINES EACH YEAR, WITH A GROWING LIBRARY OF GUIDELINE SUMMARIES THAT HAVE BEEN TRANSLATED INTO SPANISH. A TOTAL OF 39 GUIDELINE PRODUCTS WERE PUBLISHED IN THE JCO FAMILY OF JOURNALS IN 2024, INCLUDING SEVERAL RAPID RECOMMENDATIONS AND MULTIPLE ITERATIONS OF ASCO'S COMPREHENSIVE LIVING GUIDELINE THAT ADDRESSES THE CARE OF PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER.Expenses $9,146,436 · grants $8,000 · revenue $1,452,853
- POLICY:IN COLLABORATION WITH VOLUNTEER EXPERTS, ASCO WORKS TO ADDRESS A WIDE RANGE OF POLICY ISSUES THAT IMPACT THE CANCER CARE DELIVERY SYSTEM AND PEOPLE WITH CANCER. POLICY IS CONVEYED IN FORMAL STATEMENTS PUBLISHED IN ASCO JOURNALS, AND IN PUBLIC FACING COMMUNICATIONS CHANNELS. AREAS OF FOCUS INCLUDE QUALITY AND ACCESS TO CARE, INSURANCE ISSUES, COST, PREVENTION, SURVIVORSHIP, REIMBURSEMENT, AND SUPPORT FOR CLINICAL CANCER RESEARCH. IN 2024, ASCO CONTINUED TO DRAW PUBLIC ATTENTION TO THE PERSISTENT CRISIS OF DRUG SHORTAGES, THE ONGOING AND WORSENING HARMS RELATED TO AGGRESSIVE UTILIZATION MANAGEMENT PRACTICES, THE NEED TO SUSTAIN ACCESS TO EVIDENCE BASED CANCER CARE, THE NEED TO BALANCE BENEFITS/HARMS ASSOCIATED WITH USE OF ARTIFICIAL INTELLIGENCE IN CANCER CARE, AND THE IMPORTANCE OF TELEMEDICINE AS A COMPONENT OF HEALTH CARE DELIVERY.CENTER FOR GLOBAL IMPACT (CGI):ASCO'S INTERNATIONAL AFFAIRS DEPARTMENT HAS TRANSITIONED TO THE CENTER FOR GLOBAL IMPACT (CGI). CGI PARTNERS ACROSS ASCO AND ONCOLOGY COMMUNITIES WORLDWIDE TO INTEGRATE GLOBAL PERSPECTIVES INTO ASCO STRATEGIES AND OPERATIONS, AND TO CATALYZE AND ADVANCE ASCO'S GLOBAL IMPACT GOALS AS DIRECTED BY THE SOCIETY'S MISSION, VISION, AND STRATEGIC PLANS. CGI SERVES AS A RESOURCE ACROSS ASCO FOR GLOBAL ISSUES RELEVANT TO ASCO, WITH A PARTICULAR EMPHASIS ON VOLUNTEER ENGAGEMENT, DIPLOMACY, STRATEGIC PLANNING, PROGRAM DELIVERY, AND GLOBAL OPERATIONS. EXAMPLES OF OPERATIONS ARE AS FOLLOWS:- JOINT SESSIONS- INTERNATIONAL CANCER CORPS- INTERNATIONAL COURSES- INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)SCIENTIFIC PUBLICATIONS:ASCO PRODUCES A NUMBER OF PROFESSIONAL PUBLICATIONS AND GENERAL PUBLICATIONS FOCUSED ON CLINICAL ONCOLOGY. ASCO PUBLISHES HIGH-QUALITY, PEER-REVIEWED SCIENTIFIC PAPERS IN ITS JOURNALS: - JOURNAL OF CLINICAL ONCOLOGY (JCO)- JCO ONCOLOGY PRACTICE (JCO OP)- JCO GLOBAL ONCOLOGY (JCO GO)- JCO CLINICAL CANCER INFORMATICS (JCO CCI)- JCO PRECISION ONCOLOGY (JCO PO)- JCO ONCOLOGY ADVANCES (JCO OA)- ASCO DAILY NEWSASCO ALSO PROVIDES CONTENT AND DISTRIBUTION LISTS FOR TRADE PUBLICATIONS. WHILE NOT OWNED OR PUBLISHED BY ASCO, THE PUBLICATIONS COVER NEWS AND INFORMATION OF INTEREST TO THE PROFESSIONAL ONCOLOGY COMMUNITY.EDUCATION AND PROFESSIONAL DEVELOPMENT:IN 2024, ASCO LAUNCHED THE INAUGURAL LEADERSHIP DEVELOPMENT PROGRAM (LDP): LATIN AMERICA CLASS OF 12, CREATING A NETWORK OF PHYSICIAN LEADERS TO ADVANCE CANCER CARE. IN 2024, ASCO HAD RECORD VIRTUAL MENTORING PROGRAM PARTICIPATION (68% INCREASE), RESULTING IN THE CREATION OF A TECHNOLOGICAL SOLUTION TO MEET THE DEMAND. THE IN-TRAINING EXAM FOR ONCOLOGY FELLOWS HAD RECORD PARTICIPATION WITH 2333 TRAINEES FROM 20 COUNTRIES ACROSS THE GLOBE PARTICIPATING. ALL PROGRAMS SERVE THE PURPOSE OF BUILDING THE WORKFORCE.Expenses $20,299,067 · grants $72,500 · revenue $22,149,676
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 13-6180380
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1965
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G9XC)
- Assets (IRS master file)
- $321,716,381
- Income (IRS master file)
- $177,189,397
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $159,100,585 | $143,670,256 | $321,716,381 | XML |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $174,337,293 | $155,488,043 | $296,538,439 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $146,139,860 | $144,269,886 | $251,452,025 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-6180380).
Questions about AMERICAN SOCIETY OF CLINICAL ONCOLOGY
- What is the EIN of AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- The employer identification number (EIN) of AMERICAN SOCIETY OF CLINICAL ONCOLOGY is 13-6180380.
- Is AMERICAN SOCIETY OF CLINICAL ONCOLOGY tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1965.
- Are donations to AMERICAN SOCIETY OF CLINICAL ONCOLOGY tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does AMERICAN SOCIETY OF CLINICAL ONCOLOGY file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of AMERICAN SOCIETY OF CLINICAL ONCOLOGY due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did AMERICAN SOCIETY OF CLINICAL ONCOLOGY last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- The 990 for the year ended December 31, 2024 names CLIFFORD HUDIS MD CEO.
- Who are the officers and directors of AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- The 990 for the year ended December 31, 2024 lists 40 people; 17 received compensation from the organization, the highest $1,114,041 (CLIFFORD A HUDIS MD, CEO).
- How much revenue does AMERICAN SOCIETY OF CLINICAL ONCOLOGY have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $159,100,585, expenses of $143,670,256 and total assets of $321,716,381 at year end.
Other nonprofits in ALEXANDRIA
- PUBLIC HEALTH ACCREDITATION BOARD EIN 26-0333211 · last filed 990 for 2025
- AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES EIN 23-7373091 · last filed 990 for 2025
- NATIONAL PSORIASIS FOUNDATION EIN 93-0571472 · last filed 990 for 2025
- AMER ACAD OF OTOLARNYGOLOGY HEAD & NECK SURGERY FOUNDATION INC EIN 52-1219434 · last filed 990 for 2025
- SOCIETY OF GENERAL INTERNAL MEDICINE EIN 23-2532466 · last filed 990 for 2025
- NATIONAL CERTIFICATION BOARD FOR ACUPUNCTURE AND HERBAL MEDICINE EIN 11-2760706 · last filed 990 for 2024
- AMERICAN COUNCIL OF THE BLIND INC EIN 58-0914436 · last filed 990 for 2025
- AEROSPACE MEDICAL ASSOCIATION EIN 30-0697646 · last filed 990 for 2025
All nonprofits in ALEXANDRIA · Virginia · Voluntary health associations and medical disciplines